After the U.S. Drug Enforcement Administration established a new rule regarding marijuana extracts, the hemp industry had no choice, but to face them in court. The government agency basically wants the industry to provide a control number to trace the amounts of cannabis from the amounts of marijuana produced because they treat these two extracts differently.
The Controversial Move
The Denver’s Hoban Law Group who represents the Hemp Industries Association, Centuria Natural Foods and RMH Holdings LLC, submitted a judicial review action against the DEA stating that they overstepped their boundaries when they established the said rule.
According to their attorneys, this move allegedly puts the thriving hemp and cannabis industry, as well as, an assortment of hemp-based products currently sold on the market at risk. They are claiming that this will endanger the agricultural (revival), economy and employment conditions.
The Reason for the Ruling
The DEA officials revealed that the assigned code number will help them trace the materials for research purposes. They even added that it would assist them in adhering to the treaty provisions. Nevertheless, the industry is worried that this might cause the federal agencies to perceive products created from hemp and marijuana as illegal.
They mainly wanted the court to agree to a judicial review of the final ruling because they believe that this move contradicts the law, such as the Farm Bill, the Agricultural Act of 2014 and the U.S. Controlled Substances Act. Hoban says that a scheduling action would require a congressional approval.
However, the DEA spokesman Russ Baer clarified that the new rule doesn’t alter the already-existing enforcement policies. They said that the industry just misread their laws regarding CBD and they’ve given them a month to comply.